[1]
I. Bergo and Y. Pastorello, “Utilization of lipoxins and other specialised pro-resolving mediators in the prevention and treatment of diabetic nephropathy and diabetic cardiovascular disease”, amm, vol. 70, no. 4, Nov. 2024.